Nile Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Nile Therapeutics Inc
TickerCAPR
CIK #0001133869
CUSIP14070B309
SectorLife Sciences - Pharmaceutical Preparations
Address4 West 4th Ave Suite 400, San Mateo, CA 94402
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Capricor Therapeutics Inc 2017-05-19 3.7 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
Nile Therapeutics Inc 2011-06-27 2.5 M Exemption: 506 · Duration: One year or less · Commission: $175,000 · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001133869] 10-K
[0001133869] 10-Q
[0001133869] 3
[0001133869] 4
[0001133869] 5
[0001133869] 8-K
[0001133869] D
[0001133869] SC 13D
[0001133869] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Suvretta Capital Management LLC Capricor Therapeutics Inc [2026-02-26] 0.0
Tang Capital Management LLC Capricor Therapeutics Inc [2026-01-26] 0.0
Vanguard Group Inc Capricor Therapeutics Inc [2025-07-29] 0.0
Vanguard Group Inc Capricor Therapeutics Inc [2025-01-30] 0.0
BlackRock Inc Capricor Therapeutics Inc [2024-11-12] 5.4
BlackRock Inc Capricor Therapeutics Inc [2024-10-24] 5.4
Highbridge Capital Management LLC Capricor Therapeutics Inc [2024-02-07] 0.1
Nippon Shinyaku Co Ltd Capricor Therapeutics Inc [2023-10-17] 6.97
Feinberg Larry N Capricor Therapeutics Inc [2021-02-08] 0.78
Armistice Capital LLC Capricor Therapeutics Inc [2019-12-27] 4.99
Marban Linda Capricor Therapeutics Inc [2015-05-08] 5.0
Cedars Sinai Medical Center Capricor Therapeutics Inc [2015-03-30] 13.4
MD BTI LLC Capricor Therapeutics Inc [2014-03-19] 13.3
Cedars Sinai Medical Center Capricor Therapeutics Inc [2014-02-14] 11.3
Nancelou Inc Capricor Therapeutics Inc [2013-12-04] 7.7
Coniston Corp Capricor Therapeutics Inc [2013-12-03] 5.5
Litvack Frank Capricor Therapeutics Inc [2013-12-03] 0.0
Marban Eduardo Capricor Therapeutics Inc [2013-12-03] 27.1
Form 3/4/5 Filer 2011 - 2026
Capricor Therapeutics Inc
Krasney Karen
Bergmann Anthony
Maurer Michael T
Litvack Frank
Sabar Karimah Es
Dunbar George W Jr
Auwaerter Paul Gisbert
Kelliher Mike
Marban Linda
Musket David B
Gotwals Philip J
Collier Earl M Jr
Nippon Shinyaku Co Ltd
Avat Xavier
Manzo Louis
Ascheim Deborah
Kazam Joshua A
Smith Rachel
Cedars Sinai Medical Center
Marban Eduardo
St John Edward A
Edward St John LLC
Gershell Leland
Grasmick Louis J
Schafer Gregory W
Hamer Andrew Warwick
MD BTI LLC
Davies Anthony
Horton Darlene P
Brewer Richard B
Evans Daron
Lieu Hsiao D
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Auwaerter Paul Gisbert
Stock Option (Right to Buy) · derivative
2026-01-05 Grant 15,500 $0.00
Gotwals Philip J
Stock Option (Right to Buy) · derivative
2026-01-05 Grant 15,500 $0.00
Auwaerter Paul Gisbert
Stock Option (Right to Buy) · derivative
2026-01-05 Grant 5,420 $0.00
Marban Linda
Stock Option (Right to Buy) · derivative
2026-01-05 Grant 100,000 $0.00
Kelliher Mike
Stock Option (Right to Buy) · derivative
2026-01-05 Grant 15,500 $0.00
Marban Linda
Restricted Stock Units · derivative
2026-01-05 Grant 7,500 $0.00
Litvack Frank
Stock Option (Right to Buy) · derivative
2026-01-05 Grant 50,000 $0.00
Bergmann Anthony
Stock Option (Right to Buy) · derivative
2026-01-05 Grant 25,000 $0.00
Krasney Karen
Stock Option (Right to Buy) · derivative
2026-01-05 Grant 22,500 $0.00
Bergmann Anthony
Restricted Stock Units · derivative
2026-01-05 Grant 2,500 $0.00
Auwaerter Paul Gisbert
Stock Option (Right to Buy) · derivative
2026-01-05 Grant 1,360 $0.00
Krasney Karen
Stock Option (Right to Buy) · derivative
2026-01-05 Grant 22,500 $0.00
Marban Linda
Stock Option (Right to Buy) · derivative
2026-01-05 Grant 50,000 $0.00
Dunbar George W Jr
Stock Option (Right to Buy) · derivative
2026-01-05 Grant 15,500 $0.00
Sabar Karimah Es
Stock Option (Right to Buy) · derivative
2026-01-05 Grant 15,500 $0.00
Bergmann Anthony
Stock Option (Right to Buy) · derivative
2026-01-05 Grant 25,000 $0.00
Musket David B
Stock Option (Right to Buy) · derivative
2026-01-05 Grant 15,500 $0.00
Krasney Karen
Stock Option (Right to Buy) · derivative
2025-12-30 Option exercise 2,500 $0.00
Krasney Karen
Common Stock
2025-12-30 Option exercise 2,500 $1.39 3,475
Dunbar George W Jr
Common Stock
2025-12-19 Option exercise 3,000 $1.39 4,170
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 181 38,754,061
2025-12-31 138 34,213,788
2025-09-30 121 21,284,670
2025-06-30 121 24,130,419
2025-03-31 131 20,834,980
2024-12-31 118 20,704,761
2024-09-30 81 11,597,027
2024-06-30 64 7,018,934
2024-03-31 57 5,202,599
2023-12-31 39 4,282,604
2023-09-30 35 5,747,883
2023-06-30 33 2,689,764
Form 13F Holdings
Firm Period DFND Voting Shares
Moody Aldrich Partners LLC [2026-06-30] SOLE 77,240 177,754
Curated Wealth Partners LLC [2026-06-30] OTR 0 50,000
Goalvest Advisory LLC [2026-06-30] SOLE 2,100 2,100
Activest Wealth Management [2026-06-30] SOLE 0 2,000
IFP Advisors LLC [2026-06-30] SOLE 325 325
Gamma Investing LLC [2026-06-30] DFND 323 323
Farther Finance Advisors LLC [2026-06-30] SOLE 0 36
Hughes Financial Services LLC [2026-06-30] SOLE 12 12
Wolff Wiese Magana LLC [2026-06-30] SOLE 6 6
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com